Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation

NCT00348101 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Combined therapy with enoximone and esmolol

Sponsor

Klinikum Ludwigshafen